HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiang-Yang Zhu Selected Research

Renal Artery Obstruction (Renal Artery Stenosis)

1/2021Impaired immunomodulatory capacity in adipose tissue-derived mesenchymal stem/stromal cells isolated from obese patients.
6/2020Extracellular vesicles released by adipose tissue-derived mesenchymal stromal/stem cells from obese pigs fail to repair the injured kidney.
1/2020Selective intrarenal delivery of mesenchymal stem cell-derived extracellular vesicles attenuates myocardial injury in experimental metabolic renovascular disease.
10/2018Targeted Imaging of Renal Fibrosis Using Antibody-Conjugated Gold Nanoparticles in Renal Artery Stenosis.
1/2017Mesenchymal stem cell-derived extracellular vesicles attenuate kidney inflammation.
3/2015Circulating and renal vein levels of microRNAs in patients with renal artery stenosis.
2/2014Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis.
10/2013Angiotensin receptor blockade has protective effects on the poststenotic porcine kidney.
1/2013Mesenchymal stem cells improve medullary inflammation and fibrosis after revascularization of swine atherosclerotic renal artery stenosis.
1/2013Mesenchymal stem cells and endothelial progenitor cells decrease renal injury in experimental swine renal artery stenosis through different mechanisms.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiang-Yang Zhu Research Topics

Disease

28Inflammation (Inflammations)
01/2021 - 08/2006
21Fibrosis (Cirrhosis)
01/2021 - 10/2004
12Renal Artery Obstruction (Renal Artery Stenosis)
01/2021 - 06/2010
12Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2020 - 02/2015
10Hypoxia (Hypoxemia)
01/2022 - 05/2004
8Renovascular Hypertension (Goldblatt Syndrome)
01/2022 - 04/2007
8Obesity
06/2021 - 08/2013
7Solitary Kidney
01/2020 - 06/2010
6Hypertension (High Blood Pressure)
10/2019 - 03/2006
6Atherosclerosis
03/2015 - 05/2004
4Hypercholesterolemia
02/2015 - 05/2004
3Kidney Diseases (Kidney Disease)
03/2022 - 09/2012
2Ischemia
01/2022 - 10/2019
2Body Weight (Weight, Body)
11/2019 - 04/2016
2Vascular Remodeling
02/2018 - 01/2013
2Insulin Resistance
02/2018 - 02/2015
2Hypertrophy
01/2015 - 04/2007
2Microvascular Rarefaction
09/2014 - 04/2012
2Pathologic Constriction (Stenosis)
10/2013 - 12/2010
2Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
04/2007 - 03/2006
1Lupus Nephritis
03/2022
1Diabetic Nephropathies (Diabetic Nephropathy)
03/2022
1Dyslipidemias (Dyslipidemia)
11/2019
1Neuroinflammatory Diseases
05/2019
1Mitochondrial Diseases (Mitochondrial Disease)
01/2017
1Sepsis (Septicemia)
01/2017
1Acute Kidney Injury (Acute Renal Failure)
01/2017
1Reperfusion Injury
11/2012
1Arthritis (Polyarthritis)
12/2010
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2010

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2004
13Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 05/2004
8MicroRNAs (MicroRNA)IBA
01/2021 - 03/2015
8erucylphosphocholineIBA
01/2015 - 05/2010
7CytokinesIBA
01/2020 - 08/2013
6salicylhydroxamic acid (SHAM)IBA
01/2021 - 12/2010
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2020 - 04/2007
5Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 05/2004
5CholesterolIBA
11/2019 - 07/2009
5CollagenIBA
10/2018 - 07/2007
4Oxygen (Dioxygen)IBA
06/2015 - 04/2011
3Messenger RNA (mRNA)IBA
10/2019 - 10/2004
3Acetylcholine (Acetylcholine Chloride)FDA Link
04/2016 - 10/2012
3FructoseIBA
04/2016 - 08/2013
3Simvastatin (Zocor)FDA LinkGeneric
05/2010 - 04/2007
2Biological ProductsIBA
01/2022 - 10/2016
2DNA (Deoxyribonucleic Acid)IBA
06/2021 - 08/2015
2ProteomeIBA
03/2020 - 01/2019
2Mitochondrial Proteins (Mitochondrial Protein)IBA
01/2019 - 08/2015
2Transforming Growth Factors (Transforming Growth Factor)IBA
01/2018 - 07/2007
2ChemokinesIBA
01/2018 - 10/2009
2IsoprostanesIBA
04/2015 - 01/2015
2LipidsIBA
02/2015 - 04/2007
2NADPH Oxidases (NAD(P)H oxidase)IBA
06/2012 - 10/2004
2Adenosine (Adenocard)FDA LinkGeneric
04/2012 - 02/2011
2Superoxides (Superoxide)IBA
10/2009 - 10/2004
2AntioxidantsIBA
08/2006 - 05/2004
1Biomarkers (Surrogate Marker)IBA
03/2022
1Angiopoietin-1IBA
01/2022
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
06/2021
1Histones (Histone)IBA
06/2021
1histone H3 trimethyl Lys4IBA
06/2021
1Mitogen-Activated Protein KinasesIBA
01/2021
1CreatinineIBA
11/2019
1QuercetinIBA
11/2019
1Conditioned Culture MediaIBA
05/2019
1HomocysteineIBA
01/2019
1nephrinIBA
01/2019
1GoldIBA
10/2018
1Glucose (Dextrose)FDA LinkGeneric
02/2018
1Insulin (Novolin)FDA Link
02/2018
1Therapeutic UsesIBA
01/2018
1InterleukinsIBA
01/2017
1human MIRN-4456 microRNAIBA
01/2017
1Interleukin-10 (Interleukin 10)IBA
01/2017
1Triglycerides (Triacylglycerol)IBA
02/2015
1Cardiolipins (Cardiolipin)IBA
09/2014
1Valsartan (Vals)FDA Link
10/2013
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
10/2013
1Angiotensin Receptor AntagonistsIBA
10/2013
1arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA
11/2012
1Mitochondrial Permeability Transition PoreIBA
11/2012
1deoxyhemoglobinIBA
10/2012
1Furosemide (Lasix)FDA LinkGeneric
10/2012
1Peptides (Polypeptides)IBA
09/2012
1OsteopontinIBA
09/2012
1Apolipoproteins E (ApoE)IBA
09/2012
1humaninIBA
09/2012
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
06/2012
1Estrogens (Estrogen)FDA Link
04/2012
1AldosteroneIBA
04/2012
1Angiotensin IIIBA
10/2011
1bindaritIBA
10/2009
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2009
1Hydroxyproline (4 Hydroxyproline)IBA
10/2009
1Oxidoreductases (Dehydrogenase)IBA
10/2009
1NADP (NADPH)IBA
10/2009

Therapy/Procedure

4Therapeutics
01/2021 - 06/2010
1Precision Medicine
03/2022
1Catheters
07/2009